Atlas Trials

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

Clinical trial NCT00283829 · COMPLETED

Trial details

NCT number
NCT00283829
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2002-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.